FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/09/2026
Back to search
Official data from USPTO
REDOXIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/09/2026
Trademark type
Combined
Nice classes
42
Filing date
02/14/2025
Registration date
12/09/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Lund, SE
Examiner
HAYS, CANDACE W
Current location
Historical data usage
Mark description
The mark consists of the literal element "REDOXIS" in lowercase letters. To the left of "REDOXIS" is a red circular icon containing a white abstract figure resembling a person with raised arms. The "X" in "REDOXIS" is also represented in red whilst the remaining letters are in black.
Holders and representatives
Holders
Redoxis AB
Representatives
Thomas Ewing AWA AB
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research; biological researchclinical research in the fields of immunologyautoimmunitydiagnostics and treatment of inflammation and neurodegenerative diseasesmedical research; biological research services; pharmaceutical research services; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; advisory services relating to scientific research; pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; medical research laboratory services; laboratory research services relating to pharmaceuticals
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/23/2026
FIMP
FINAL DISPOSITION PROCESSED
06/23/2026
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
03/31/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/09/2026
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/06/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/26/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
12/12/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/21/2025
PUBO
PUBLISHED FOR OPPOSITION
10/21/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/15/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/19/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/19/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2025
RFNT
REFUSAL PROCESSED BY IB
09/12/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/27/2025
RFRR
REFUSAL PROCESSED BY MPU
08/27/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/24/2025
CNRT
NON-FINAL ACTION WRITTEN
07/23/2025
DOCK
ASSIGNED TO EXAMINER
07/22/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/04/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/04/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/03/2025
Continuous trademark protection
Get notified about every new filing that threatens REDOXIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.